{"id":"NCT01613326","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)","officialTitle":"A 12-week Treatment, Randomized, Blinded, Double-dummy, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of NVA237 (50 µg o.d.) Compared to Tiotropium (18 µg o.d.) in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-06","primaryCompletion":"2013-01","completion":"2013-01","firstPosted":"2012-06-07","resultsPosted":"2014-04-23","lastUpdate":"2014-04-23"},"enrollment":657,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"NVA237","otherNames":[]},{"type":"DRUG","name":"Tiotropium","otherNames":[]},{"type":"DRUG","name":"Placebo to tiotropium","otherNames":[]},{"type":"DRUG","name":"Placebo to NVA237","otherNames":[]},{"type":"DRUG","name":"salbutamol/albuterol","otherNames":[]}],"arms":[{"label":"NVA237","type":"EXPERIMENTAL"},{"label":"Tiotropium","type":"ACTIVE_COMPARATOR"}],"summary":"This study compared the efficacy and safety of NVA237 with tiotropium in patients with moderate to severe COPD. Tiotropium belongs to the same drug class as NVA237.","primaryOutcome":{"measure":"Trough Forced Expiratory Volume in 1 Second (FEV1) After 12 Weeks of Treatment (Non-inferiority Analysis)","timeFrame":"Week 12","effectByArm":[{"arm":"NVA237","deltaMin":1.405,"sd":0.0173},{"arm":"Tiotropium","deltaMin":1.405,"sd":0.017}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":77,"countries":["Canada","Croatia","Czechia","Estonia","France","Germany","Guatemala","India","Latvia","Lithuania","Philippines","Poland","South Africa","South Korea","Taiwan"]},"refs":{"pmids":["24438744"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":327},"commonTop":["Chronic obstructive pulmonary disease"]}}